Why the Elmo share price is going NOWHERE on its quarterly update

The Elmo Ltd (ASX:ELO) share price is marginally higher over the past year.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

a woman

The Elmo Ltd (ASX: ELO) share price is flat at $5.17 today with just $3,100 worth of shares traded as at 11.30am despite the software-as-a-service HR business reporting a quarterly operating cash profit of $48,000 on revenue of $9.79 million for the quarter ending December 31 2018.

The top-line result was up an impressive 75% on the prior corresponding quarter, although a disappointment is that the $9.79 million is marginally down on the two prior quarters' results.

Elmo blamed this on the "seasonality of collections", with pressure on it to now deliver a big third quarter in FY 2019 in terms of cash receipts.

The group also completed the acquisitions of HROnboard and BoxSuite around the turn of the year and reports that it still has a pipeline of acquisition opportunities.

It had cash on hand of $39 million as at December 31 2018, with the CEO commenting that given its market opportunity its strategy remains to invest for growth even at the expense of profitability.

Elmo shares are up around 4% over the past year and it's a rising software-as-a-service small cap worth watching alongside the likes of Pro Medicus Limited (ASX: PME) and Nearmap Ltd (ASX: NEA).

Tom Richardson owns shares in Pro Medicus, Elmo and Nearmap. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of ELMOSFTWRE FPO. The Motley Fool Australia's parent company Motley Fool Holdings Inc. recommends Pro Medicus Ltd. The Motley Fool Australia owns shares of and has recommended Nearmap Ltd. and Pro Medicus Ltd. The Motley Fool Australia has recommended ELMOSFTWRE FPO. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Three children wearing athletic short and singlets stand side by side on a running track wearing medals around their necks and standing with their hands on their hips.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a rough start to the trading week this Monday.

Read more »

A man looking at his laptop and thinking.
Broker Notes

Forget CBA shares and buy this ASX ETF: experts

Here's what experts are saying about these two investment options.

Read more »

Middle age caucasian man smiling confident drinking coffee at home.
Broker Notes

Buy, hold, sell: BHP, Guzman Y Gomez, and Pro Medicus shares

Are brokers bullish or bearish on these names? Let's find out.

Read more »

Red buy button on an Apple keyboard with a finger on it.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to buy these shares.

Read more »

Humanoid robot analysing the stock market, symbolising artificial intelligence shares.
Broker Notes

Up 109% since November, are Appen shares still a buy today?

A leading expert digs into the outlook for Appen shares amid the rise of AI.

Read more »

Paper aeroplane going down on a chart, symbolising a falling share price.
Travel Shares

Why Web Travel shares are sliding as fresh takeover hopes return

Web Travel shares sink as investors weigh CEO succession and takeover risk.

Read more »

Shot of a young businesswoman looking stressed out while working in an office.
Share Fallers

Why 4DMedical, Brainchip, Catapult, and Star Entertainment shares are falling today

These shares are starting the week in the red. But why>

Read more »

A white and black clock face is shown with three hands saying Time to Buy reflecting Citi's view that it's time to buy ASX 200 banks
Broker Notes

3 reasons to buy Pro Medicus shares today

Two leading investment analysts believe Pro Medicus shares are primed for a rebound.

Read more »